文献速递真菌感染艾滋病与性传播感染

隐球菌性脑膜脑炎:行动刻不容缓

Cryptococcal meningoencephalitis: time for action.
PubMed 文献 · Lancet Infect Dis · 2021-04-16

隐球菌性脑膜脑炎虽可预防可治疗,但仍导致高发病率和高死亡率,最大疾病负担在低收入和中等收入国家的HIV感染者中。临床试验中最佳抗真菌诱导方案(两性霉素B脱氧胆酸盐1·0 mg/kg/日联合氟胞嘧啶100·0 mg/kg/日,共7天)10周死亡率为24%。综述总结死亡率过高的原因、有生存获益的干预措施及知识与实践差距。

要点

  • HIV感染者是隐球菌性脑膜脑炎最大疾病负担人群,尤其在低收入和中等收入国家。
  • 最佳诱导方案(两性霉素B脱氧胆酸盐联合氟胞嘧啶7天)临床试验10周死亡率仍达24%。
  • 需扩大干预项目实施,重视针对各国具体情况的实施科学。

核心结论

  • 隐球菌性脑膜脑炎仍与过高发病率和死亡率相关,全球处于认识、研究和行动的关键转折点。

研究设计与样本

  • 综述总结隐球菌性脑膜脑炎死亡率过高的原因、有生存获益的干预措施及知识与实践差距。

主要发现

  • 最大疾病负担在低收入和中等收入国家的HIV感染者中。
  • 临床试验中最佳抗真菌诱导方案(两性霉素B脱氧胆酸盐1·0 mg/kg/日联合氟胞嘧啶100·0 mg/kg/日,共7天)10周死亡率为24%。

关键数值与推荐

  • 最佳抗真菌诱导方案为两性霉素B脱氧胆酸盐1·0 mg/kg/日联合氟胞嘧啶100·0 mg/kg/日,共7天。

临床怎么用

  • 需扩大干预项目实施,特别关注针对各国具体情况的实施科学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cryptococcal meningoencephalitis was first described over a century ago. This fungal infection is preventable and treatable yet continues to be associated with excessive morbidity and mortality. The largest burden of disease resides in people living with HIV in low-income and middle-income countries. In this group, mortality with the best antifungal induction regimen (7 days of amphotericin B deoxycholate [1·0 mg/kg per day] and flucytosine [100·0 mg/kg per day]) in a clinical trial setting was 24% at 10 weeks. The world is now at an inflection point in terms of recognition, research, and action to address the burden of morbidity and mortality from cryptococcal meningoencephalitis. However, the scope of interventional programmes needs to increase, with particular attention to implementation science that is specific to individual countries. This Review summarises causes of excessive mortality, interventions with proven survival benefit, and gaps in knowledge and practice that contribute to the ongoing high death toll from cryptococcal meningoencephalitis. TRANSLATIONS: For the Vietnamese and Chichewa translations of the abstract see Supplementary Materials section.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Stott KE, Loyse A, Jarvis JN, et al. Cryptococcal meningoencephalitis: time for action. Lancet Infect Dis. 2021. PMID: 33872594. doi:10.1016/S1473-3099(20)30771-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。